206 related articles for article (PubMed ID: 12717631)
1. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides.
Kong JT; Grigg ME; Uyetake L; Parmley S; Boothroyd JC
J Infect Dis; 2003 May; 187(9):1484-95. PubMed ID: 12717631
[TBL] [Abstract][Full Text] [Related]
2. Testing New Peptides From
Xicoténcatl-García L; Enriquez-Flores S; Correa D
Front Cell Infect Microbiol; 2019; 9():368. PubMed ID: 31709197
[No Abstract] [Full Text] [Related]
3. Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis.
Cardona N; de-la-Torre A; Siachoque H; Patarroyo MA; Gomez-Marin JE
Exp Parasitol; 2009 Oct; 123(2):199-202. PubMed ID: 19567250
[TBL] [Abstract][Full Text] [Related]
4. Serotyping of
Arranz-Solís D; Cordeiro C; Young LH; Dardé ML; Commodaro AG; Grigg ME; Saeij JPJ
Front Cell Infect Microbiol; 2019; 9():408. PubMed ID: 31850240
[TBL] [Abstract][Full Text] [Related]
5. Serotyping of naturally Toxoplasma gondii infected meat-producing animals.
Sousa S; Canada N; Correia da Costa JM; Dardé ML
Vet Parasitol; 2010 Apr; 169(1-2):24-8. PubMed ID: 20083355
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and Beverley strain-induced anti-Toxoplasma gondii antibodies.
Kato M; Claveria FG; Maki Y; Sanda K; Tanaka T; Omata Y; Nagasawa H; Suzuki N
Pathobiology; 2007; 74(1):50-6. PubMed ID: 17496433
[TBL] [Abstract][Full Text] [Related]
7. A combination of GRA3, GRA6 and GRA7 peptides offer a useful tool for serotyping type II and III
Arranz-Solís D; Tana LR; Tejerina-de-Uribe E; López-Ureña NM; Koudela B; Francia ME; Ortega-Mora LM; Álvarez-García G
Front Cell Infect Microbiol; 2024; 14():1384393. PubMed ID: 38720960
[TBL] [Abstract][Full Text] [Related]
8. Use of GRA6-derived synthetic polymorphic peptides in an immunoenzymatic assay to serotype Toxoplasma gondii in human serum samples collected from three continents.
Sousa S; Ajzenberg D; Vilanova M; Costa J; Dardé ML
Clin Vaccine Immunol; 2008 Sep; 15(9):1380-6. PubMed ID: 18667636
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii: enzyme-linked immunosorbent assay using different fragments of recombinant microneme protein 1 (MIC1) for detection of immunoglobulin G antibodies.
Holec L; Gasior A; Brillowska-Dabrowska A; Kur J
Exp Parasitol; 2008 May; 119(1):1-6. PubMed ID: 18207143
[TBL] [Abstract][Full Text] [Related]
10. Selection of polymorphic peptides from GRA6 and GRA7 sequences of Toxoplasma gondii strains to be used in serotyping.
Sousa S; Ajzenberg D; Marle M; Aubert D; Villena I; da Costa JC; Dardé ML
Clin Vaccine Immunol; 2009 Aug; 16(8):1158-69. PubMed ID: 19494084
[TBL] [Abstract][Full Text] [Related]
11. Use of SAG2A recombinant Toxoplasma gondii surface antigen as a diagnostic marker for human acute toxoplasmosis: analysis of titers and avidity of IgG and IgG1 antibodies.
Béla SR; Oliveira Silva DA; Cunha-Júnior JP; Pirovani CP; Chaves-Borges FA; Reis de Carvalho F; Carrijo de Oliveira T; Mineo JR
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):245-54. PubMed ID: 18703303
[TBL] [Abstract][Full Text] [Related]
12. Serodiagnosis of recently acquired Toxoplasma gondii infection in pregnant women using enzyme-linked immunosorbent assays with a recombinant dense granule GRA6 protein.
Golkar M; Azadmanesh K; Khalili G; Khoshkholgh-Sima B; Babaie J; Mercier C; Brenier-Pinchart MP; Fricker-Hidalgo H; Pelloux H; Cesbron-Delauw MF
Diagn Microbiol Infect Dis; 2008 May; 61(1):31-9. PubMed ID: 18249081
[TBL] [Abstract][Full Text] [Related]
13. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America).
Peyron F; Lobry JR; Musset K; Ferrandiz J; Gomez-Marin JE; Petersen E; Meroni V; Rausher B; Mercier C; Picot S; Cesbron-Delauw MF
Microbes Infect; 2006 Aug; 8(9-10):2333-40. PubMed ID: 16938480
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clonal type-specific antibody reactions in Toxoplasma gondii seropositive humans from Germany by peptide-microarray.
Maksimov P; Zerweck J; Maksimov A; Hotop A; Gross U; Spekker K; Däubener W; Werdermann S; Niederstrasser O; Petri E; Mertens M; Ulrich RG; Conraths FJ; Schares G
PLoS One; 2012; 7(3):e34212. PubMed ID: 22470537
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model.
Siachoque H; Guzman F; Burgos J; Patarroyo ME; Gomez Marin JE
Exp Parasitol; 2006 Sep; 114(1):62-5. PubMed ID: 16545806
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating antigens by ELISA using penicillinase in sera of mice infected with Toxoplasma gondii.
Bhopale GM; Naik SR
Rocz Akad Med Bialymst; 2000; 45():14-8. PubMed ID: 11712425
[TBL] [Abstract][Full Text] [Related]
17. Development of an immunochromatographic strip for the rapid detection of Toxoplasma gondii circulating antigens.
Wang YH; Li XR; Wang GX; Yin H; Cai XP; Fu BQ; Zhang DL
Parasitol Int; 2011 Jan; 60(1):105-7. PubMed ID: 21081174
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model.
Gatkowska J; Hiszczynska-Sawicka E; Kur J; Holec L; Dlugonska H
Exp Parasitol; 2006 Nov; 114(3):220-7. PubMed ID: 16707125
[TBL] [Abstract][Full Text] [Related]
19. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
Piergili Fioretti D
Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
